Teva Canada Revenue and Competitors

Affordable Healthcare for Canadians, Generic Pharmaceuticals At Teva Canada, we believe that all Canadians deserve access to innovative and affordable medications. We develop, produce and market generic pharmaceuticals, from diabetic agents to antibiotics, from heart medications to cancer treatments. We’ve been part of Canadian healthcare since 1965, when we began operations as one of the country’s first generic pharmaceutical companies. Today, we employ over 1,300 Canadians. We invest in facilities in this country–creating generic and brand-name medications. And we’re proud to be part of Teva Pharmaceutical Industries Ltd. Teva Canada Innovation is part of Teva’s Global Specialty Medicines business has a world-leading position in innovative treatments for disorders of the central nervous system (CNS), including neurological and neurodegenerative diseases, pain, and movement disorders, as well as a strong portfolio of products to address respiratory disease, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). Across its specialty medicines portfolio, Teva focuses on developing, personalizing and improving treatment of disorders for patients in CNS, respiratory, oncology, women's health and select local/regional therapeutic areas. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Learn more about Teva at: www.tevamakesmedicines.ca | www.tevacanadainnovation.com | www.tevapharm.com | www.tevacanada.com Think You Know Teva Video: https://www.youtube.com/watch?v=_onneAgyDNI We Make the Difference Video: https://www.youtube.com/watch?v=PGmabmbqhsw